17 December 2015

Disposal Completion

Merrion Pharmaceuticals plc is pleased to announce that it has completed the Disposal of certain IP assets following the satisfaction of all conditions. Merrion is now an investing company under the ESM Rules.

For reference:

Company

Merrion Pharmaceuticals plc

Dr. John Fox, CEO

+353 1 469 3719

Financial Adviser/ESM Adviser

Davy Corporate Finance

Anthony Farrell / Patrick Bance

+ 353 1 679 6363

Media Enquiries

Dempsey Corporate

Conor Dempsey

+353 86 247 9892

conor.dempsey@dempseycorporate.com

<< Back to Regulatory News

Merrion Pharmaceuticals plc issued this content on 2015-12-17 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-17 17:04:21 UTC

Original Document: http://www.merrionpharma.com/content/investors/archive/2015/171215.asp